Matthew Kaplan
Stock Analyst at Ladenburg Thalmann
(n/a)
# 1,684
Out of 4,829 analysts
27
Total ratings
n/a
Success rate
-18.77%
Average return
Main Sectors:
Stocks Rated by Matthew Kaplan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EYEN Eyenovia | Downgrades: Neutral | n/a | $1.17 | - | 1 | Nov 18, 2024 | |
| UTHR United Therapeutics | Maintains: Buy | $319 → $344 | $310.80 | +10.68% | 9 | Oct 31, 2024 | |
| URGN UroGen Pharma | Maintains: Buy | $48 → $54 | $11.14 | +380.25% | 1 | Jun 14, 2024 | |
| TGTX TG Therapeutics | Maintains: Buy | $39 → $40 | $34.99 | +14.32% | 3 | May 2, 2024 | |
| LQDA Liquidia | Maintains: Buy | $15 → $30 | $15.75 | +90.48% | 2 | Dec 21, 2023 | |
| ARDX Ardelyx | Maintains: Buy | $7.5 → $8.5 | $3.53 | +140.79% | 4 | Aug 3, 2023 | |
| AVDL Avadel Pharmaceuticals | Maintains: Buy | $15 → $16 | $9.59 | +66.84% | 1 | May 2, 2023 | |
| KPRX Kiora Pharmaceuticals | Reiterates: Buy | $1,071 | $3.19 | +33,473.67% | 2 | Feb 8, 2023 | |
| XAIR Beyond Air | Maintains: Buy | $17 → $23 | $0.20 | +11,694.87% | 1 | Jun 29, 2022 | |
| LPCN Lipocine | Upgrades: Buy | $51 | $2.92 | +1,646.58% | 1 | Dec 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $5.13 | +211.89% | 1 | Oct 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $45 | $3.27 | +1,276.15% | 1 | Jan 22, 2020 |
Eyenovia
Nov 18, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.17
Upside: -
United Therapeutics
Oct 31, 2024
Maintains: Buy
Price Target: $319 → $344
Current: $310.80
Upside: +10.68%
UroGen Pharma
Jun 14, 2024
Maintains: Buy
Price Target: $48 → $54
Current: $11.14
Upside: +380.25%
TG Therapeutics
May 2, 2024
Maintains: Buy
Price Target: $39 → $40
Current: $34.99
Upside: +14.32%
Liquidia
Dec 21, 2023
Maintains: Buy
Price Target: $15 → $30
Current: $15.75
Upside: +90.48%
Ardelyx
Aug 3, 2023
Maintains: Buy
Price Target: $7.5 → $8.5
Current: $3.53
Upside: +140.79%
Avadel Pharmaceuticals
May 2, 2023
Maintains: Buy
Price Target: $15 → $16
Current: $9.59
Upside: +66.84%
Kiora Pharmaceuticals
Feb 8, 2023
Reiterates: Buy
Price Target: $1,071
Current: $3.19
Upside: +33,473.67%
Beyond Air
Jun 29, 2022
Maintains: Buy
Price Target: $17 → $23
Current: $0.20
Upside: +11,694.87%
Lipocine
Dec 10, 2020
Upgrades: Buy
Price Target: $51
Current: $2.92
Upside: +1,646.58%
Oct 14, 2020
Initiates: Buy
Price Target: $16
Current: $5.13
Upside: +211.89%
Jan 22, 2020
Initiates: Buy
Price Target: $45
Current: $3.27
Upside: +1,276.15%